BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8651426)

  • 1. [The prognostic factors in endometrial carcinoma (EC)].
    Gorchev G
    Akush Ginekol (Sofiia); 1995; 34(2):51-3. PubMed ID: 8651426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma].
    Gorchev G; Milkov V
    Akush Ginekol (Sofiia); 1992; 31(2):32-3. PubMed ID: 1342555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
    Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
    Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
    Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of cancer of the endometrium and therapeutic implications].
    Michel G; Morice P; Castaigne D; Lanoux P; Pautier P; Lhommé C; Gerbaulet A; Duvillard P
    Contracept Fertil Sex; 1998 Jun; 26(6):452-6. PubMed ID: 9691524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients.
    Kadar N; Malfetano JH; Homesley HD
    Gynecol Oncol; 1993 Sep; 50(3):281-6. PubMed ID: 8406187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progesterone receptors in patients with endometrial cancer].
    Gorchev G; Milkov V
    Akush Ginekol (Sofiia); 1993; 32(3):32-3. PubMed ID: 8037316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
    Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
    Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
    Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
    Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in endometrial cancer. Clinicopathological correlations and prognostic significance.
    Nyholm HC
    APMIS Suppl; 1996; 65():5-33. PubMed ID: 8944054
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.
    Scholten AN; Creutzberg CL; van den Broek LJ; Noordijk EM; Smit VT
    J Pathol; 2003 Nov; 201(3):460-5. PubMed ID: 14595758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between receptor status and results of treatment in endometrial carcinoma].
    Baĭnazarova AA; Iskakova ZhK
    Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Ilić J; Babić D; Petrovecki M; Nikolić S; Marinović T; Jukić D; Vecek N
    Acta Obstet Gynecol Scand; 1994 Oct; 73(9):730-3. PubMed ID: 7976251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of hormone receptors in endometrial cancer.
    Creasman WT
    Cancer; 1993 Feb; 71(4 Suppl):1467-70. PubMed ID: 8431882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma].
    Chen YP; Shen M; Chen C
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):123-5. PubMed ID: 12536641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.